Last reviewed · How we verify
Exenatide or metformin hydrochloride — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Exenatide or metformin hydrochloride (Exenatide or metformin hydrochloride) — Beijing Chao Yang Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Exenatide or metformin hydrochloride TARGET | Exenatide or metformin hydrochloride | Beijing Chao Yang Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Exenatide or metformin hydrochloride CI watch — RSS
- Exenatide or metformin hydrochloride CI watch — Atom
- Exenatide or metformin hydrochloride CI watch — JSON
- Exenatide or metformin hydrochloride alone — RSS
Cite this brief
Drug Landscape (2026). Exenatide or metformin hydrochloride — Competitive Intelligence Brief. https://druglandscape.com/ci/exenatide-or-metformin-hydrochloride. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab